STOCK TITAN

Alimera Sciences to Present at the H.C. Wainwright Global Life Sciences Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Alimera Sciences (Nasdaq: ALIM) announces that its President and CEO, Rick Eiswirth, will present at the H.C. Wainwright Global Life Sciences Conference on March 9-10, 2021. The presentation will be available on-demand from March 9 at 7:00 am ET for 90 days. Investors can register for the conference to view the presentation and request one-on-one meetings with Mr. Eiswirth. Alimera focuses on developing prescription ophthalmology treatments for retinal diseases, addressing significant unmet needs in this area.

Positive
  • None.
Negative
  • None.

ATLANTA, March 02, 2021 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, announces that President and CEO Rick Eiswirth will present at the H.C. Wainwright Global Life Sciences Conference to be held on March 9-10, 2021.

The presentation will be available on-demand beginning March 9 at 7:00 am ET and be available for 90 days. Investors can view the presentation by registering for the conference here. Mr. Eiswirth will be available for virtual one-on-one meetings with investors on March 9-10, and meeting requests can be made on the conference website once an investor is registered.

About Alimera Sciences, Inc.

Alimera Sciences is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and affect millions of people in our aging populations. For more information, please visit www.alimerasciences.com.

For press inquiries:
Jules Abraham
for Alimera Sciences
917-885-7378
julesa@coreir.com
For investor inquiries:
Scott Gordon
for Alimera Sciences
scottg@coreir.com

        

# # #


FAQ

When is Alimera Sciences presenting at the H.C. Wainwright Global Life Sciences Conference?

Alimera Sciences will present at the H.C. Wainwright Global Life Sciences Conference on March 9-10, 2021.

How can I watch Alimera Sciences' presentation at the conference?

You can watch Alimera Sciences' presentation on-demand starting March 9 at 7:00 am ET by registering for the conference.

What is the focus of Alimera Sciences in ophthalmology?

Alimera Sciences specializes in developing treatments for retinal diseases, which are often inadequately addressed by current therapies.

Is there an opportunity to meet with Alimera Sciences' CEO during the conference?

Yes, Rick Eiswirth will be available for virtual one-on-one meetings with investors on March 9-10, 2021.

How long will Alimera Sciences' presentation be available?

The presentation will be available on-demand for 90 days after it begins on March 9.

Alimera Sciences, Inc.

NASDAQ:ALIM

ALIM Rankings

ALIM Latest News

ALIM Stock Data

301.29M
51.48M
5.35%
86.54%
1.06%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
ALPHARETTA